Valuation: Elekta AB (publ)

Market Cap 21.15B 2.23B 1.91B 1.78B 1.64B 3.07B 214B 3.13B 8.24B 107B 8.38B 8.2B 354B P/E 2027 *
14.5x
P/E 2028 * 13.1x
Enterprise Value 24.58B 2.59B 2.22B 2.07B 1.9B 3.57B 248B 3.64B 9.58B 124B 9.74B 9.53B 412B EV / Sales 2027 *
1.41x
EV / Sales 2028 * 1.33x
Free-Float
-
Yield 2027 *
4.53%
Yield 2028 * 4.96%

Last Transcript: Elekta AB (publ)

Manager TitleAgeSince
Chief Executive Officer - 31/08/2025
Director of Finance/CFO - 28/02/2026
Investor Relations Contact - 30/11/2023
Director TitleAgeSince
Director/Board Member 69 29/06/2010
Director/Board Member 70 14/09/2011
Chairman 74 02/09/2013
Change 5-day change 1-year change 3-year change Capi.($)
+1.08%-0.08% - - 2.23B
-0.32%+6.49%+29.50%+17.70% 232B
+0.79%+7.78%+7.01%-12.78% 152B
+1.64%-3.81%-19.24%+32.37% 132B
+2.75%-2.52%-51.98%+0.21% 71.55B
+0.11%-1.56%+11.11%+18.14% 51.78B
+0.74%+2.19%-15.94%-11.68% 51.75B
+1.42%+6.94%+35.59%+33.64% 44.14B
+0.84%-0.97%+40.54%+52.78% 39.76B
+0.78%+1.32%+2.07%+8.26% 33.45B
Average +0.98%+0.46%+4.30%+15.40% 89.84B
Weighted average by Cap. +0.77%+1.38%+5.75%+13.18%

Financials

2027 *2028 *
Net sales 17.41B 1.84B 1.57B 1.47B 1.35B 2.53B 176B 2.58B 6.78B 88.07B 6.9B 6.75B 292B 18.14B 1.91B 1.64B 1.53B 1.4B 2.64B 183B 2.69B 7.07B 91.77B 7.19B 7.03B 304B
Net income 1.46B 154M 132M 123M 113M 212M 14.75B 216M 569M 7.39B 579M 566M 24.47B 1.63B 172M 147M 137M 126M 236M 16.43B 241M 634M 8.23B 645M 631M 27.25B
Net Debt 3.43B 362M 310M 289M 265M 499M 34.65B 509M 1.34B 17.36B 1.36B 1.33B 57.49B 2.96B 312M 267M 249M 229M 430M 29.85B 438M 1.15B 14.96B 1.17B 1.15B 49.53B
Logo Elekta AB (publ)
Elekta AB (publ) is a Sweden-based medical technology company which aims to improve, prolong and save lives through clinical solutions for treating cancer and brain disorders. The Company offers and develops systems for radiation therapy and radio-surgery, as well as software systems that enhance workflow efficiency throughout the entire spectrum of cancer care. Elekta AB (publ) develops clinical treatment solutions for radiation therapy and radiosurgery, as well as work flow-enhancing software systems, across the spectrum of cancer care. The Company provides clinical solutions for image guided radiation therapy and stereotactic radiosurgery, giving oncologists and neurosurgeons an unmatched capability to treat tumors and functional targets with ultra-high precision while sparing healthy tissue.
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-